Revance Reports Second Quarter 2022 Financial Results, Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Revance Reports Second Quarter 2022 Financial Results, Provides Corporate Update
REVANCE THERAP (NASDAQ: RVNC) Delayed: 3.65 --0 (-0%)
Previous Close $3.65    52 Week High $41.12 
Open $3.65    52 Week Low $12.35 
Day High $3.65    P/E N/A 
Day Low $3.65    EPS $-27.14 
Volume 400,000